Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 20,077-20,088 of 23,847

Drug study icon

CompletedNCT01104766

Safety and Efficacy of Cariprazine in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States, Romania, Russia, ...
Sponsor: Forest Laboratories
Condition: Schizophrenia

Drug study icon

CompletedNCT01104779

Safety and Efficacy of Cariprazine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Costa Mesa

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States, Colombia, India, ...
Sponsor: Forest Laboratories
Condition: Schizophrenia

Other study type icon

CompletedEUCTR 2007-001335-54

SAFETY AND EFFICACY OF CIMICOXIB, A SELECTIVE COX-2 INHIBITOR, IN COMBINATION WITH SERTRALINE COMPARED TO SERTRALINE COMBINED WITH PLACEBO IN TREATMENT OF MAJOR DEPRESSION

This study is completed in Germany, in Czechia, and in Austria. It focuses on depression.

In Germany

DepressionOther

Countries: Germany, Czechia, Austria
Sponsor: Affectis Pharmaceuticals AG
Condition: Depression

Behavioral study icon

CompletedNCT00364910

Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New York

PTSDBehavioralOver 21 Years

Countries: United States
Sponsor: Icahn School of Medicine at Mount Sinai
Condition: PTSD

Drug study icon

CompletedNCT00419445

Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Washington D.C.

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: CoMentis
Condition: ADHD

Drug study icon

CompletedNCT05071430

Safety and Efficacy of HB-1 for Panic Disorder

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove

AnxietyDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: HB BioTech, LLC
Condition: Anxiety

Drug study icon

Active Not RecruitingNCT06916403

Safety and Efficacy of Ketamine Intravenous Infusions in the Treatment of Fibromyalgia

This summary needs review. Please check the official study record and contact the research team for details.

In Thornhill

DepressionDrugOver 18 Years

Countries: Canada
Sponsor: Wilderman Medical Clinic
Condition: Depression

Drug study icon

CompletedNCT05200936

Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept study

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Maastricht

ADHDDrugFrom 18 Years to 65 Years

Countries: Switzerland, Netherlands
Sponsor: Definium Therapeutics US, Inc.
Condition: ADHD

Other study type icon

CompletedEUCTR 2007-000307-15

Safety and Efficacy of Melperone in the Treatment of people with Psychosis Associated with Parkinson's Disease.

This summary needs review. Please check the official study record and contact the research team for details.

In Italy

SchizophreniaOther

Countries: Italy
Sponsor: OVATION PHARMACEUTICALS INC
Condition: Schizophrenia

Drug study icon

CompletedNCT00374920

Safety and Efficacy of MEM 1003 Versus Placebo for people with Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Memory Pharmaceuticals
Condition: Bipolarity

Drug study icon

CompletedNCT00428792

Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In Freiburg im Breisgau

ADHDDrugFrom 6 Years to 12 Years

Countries: Germany
Sponsor: Novartis
Condition: ADHD

Drug study icon

CompletedNCT06854601

Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Yekaterinburg

ADHD, AnxietyDrugFrom 6 Years to 12 Years

Countries: Russia
Sponsor: Pharmasoft
Condition: ADHD, Anxiety

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.